Journal of Cerebral Blood Flow and Metabolism, ISSN 0271-678X, 2018, p. 271678X18818652
Near-infrared spectroscopy (NIRS) is used to monitor cerebral tissue oxygenation (rSO ) depending on cerebral blood flow (CBF), cerebral blood volume and blood...
cerebral oximetry | hemodialysis | NIRS | water-PET | Brain perfusion
cerebral oximetry | hemodialysis | NIRS | water-PET | Brain perfusion
Journal Article
American Heart Journal, ISSN 0002-8703, 05/2015, Volume 169, Issue 5, pp. 693 - 701.e3
Aims We examined the effect of the renin inhibitor, aliskiren, on renal blood flow (RBF) in patients with heart failure with reduced ejection fraction (HFREF)...
Journal Article
Diabetes Care, ISSN 0149-5992, 07/2017, Volume 40, Issue 7, pp. 894 - 901
OBJECTIVE: New-onset diabetes after transplantation (NODAT) is a major complication in renal transplant recipients (RTRs). Cholesterol metabolism has been...
FASTING GLUCOSE | UNITED-STATES | LIFE-STYLE INTERVENTION | METFORMIN | PRESCRIPTION | ADULTS | IMPAIRED GLUCOSE-TOLERANCE | COHORT | PREVALENCE | CARE | ENDOCRINOLOGY & METABOLISM | TRENDS | Diabetes Mellitus - blood | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Proprotein Convertase 9 - blood | Adult | Cholesterol, LDL - blood | Diabetes Mellitus - etiology | Female | Kidney Transplantation - adverse effects
FASTING GLUCOSE | UNITED-STATES | LIFE-STYLE INTERVENTION | METFORMIN | PRESCRIPTION | ADULTS | IMPAIRED GLUCOSE-TOLERANCE | COHORT | PREVALENCE | CARE | ENDOCRINOLOGY & METABOLISM | TRENDS | Diabetes Mellitus - blood | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Proprotein Convertase 9 - blood | Adult | Cholesterol, LDL - blood | Diabetes Mellitus - etiology | Female | Kidney Transplantation - adverse effects
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 12/2016, Volume 104, Issue 6, pp. 1703 - 1711
Background: Renal transplant recipients (RTRs) have commonly been urged to limit their potassium intake during renal insufficiency and may adhere to this...
C-REACTIVE PROTEIN | KIDNEY-DISEASE | UNITED-STATES | SURVIVAL | SODIUM | CARDIOVASCULAR EVENTS | kidney transplantation | MARKERS | INJURY | dietary potassium intake | graft failure | BLOOD-PRESSURE | mortality | urinary potassium excretion | ammoniagenesis | CORONARY-HEART-DISEASE | MODEL | NUTRITION & DIETETICS | DIET | DISEASE | Kidney Failure, Chronic - surgery | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Potassium, Dietary - urine | Graft Survival | Male | Potassium, Dietary - administration & dosage | Ammonia - urine | Kidney | Hypertension - etiology | Hypertension - blood | Potassium, Dietary - adverse effects | Graft Rejection - mortality | Adult | Female | Kidney Transplantation - mortality | Surveys and Questionnaires | Aged | Kidneys | Mortality | Patient outcomes | Forecasts and trends | Transplantation | Biological markers | Health aspects | Identification and classification | Risk factors | Graft rejection
C-REACTIVE PROTEIN | KIDNEY-DISEASE | UNITED-STATES | SURVIVAL | SODIUM | CARDIOVASCULAR EVENTS | kidney transplantation | MARKERS | INJURY | dietary potassium intake | graft failure | BLOOD-PRESSURE | mortality | urinary potassium excretion | ammoniagenesis | CORONARY-HEART-DISEASE | MODEL | NUTRITION & DIETETICS | DIET | DISEASE | Kidney Failure, Chronic - surgery | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Potassium, Dietary - urine | Graft Survival | Male | Potassium, Dietary - administration & dosage | Ammonia - urine | Kidney | Hypertension - etiology | Hypertension - blood | Potassium, Dietary - adverse effects | Graft Rejection - mortality | Adult | Female | Kidney Transplantation - mortality | Surveys and Questionnaires | Aged | Kidneys | Mortality | Patient outcomes | Forecasts and trends | Transplantation | Biological markers | Health aspects | Identification and classification | Risk factors | Graft rejection
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 169, Issue 5, pp. 693 - 701.e3
Aims We examined the effect of the renin inhibitor, aliskiren, on renal blood flow (RBF) in patients with heart failure with reduced ejection fraction (HFREF)...
Cardiovascular | MORTALITY | VAL-HEFT | BASE-LINE | METAANALYSIS | MYOCARDIAL-INFARCTION | CONVERTING-ENZYME-INHIBITION | KIDNEY-FUNCTION | RANDOMIZED-TRIAL | CARDIORENAL END-POINTS | PROGNOSTIC VALUE | CARDIAC & CARDIOVASCULAR SYSTEMS | Amides - pharmacology | Fumarates - therapeutic use | Humans | Middle Aged | Heart Failure - physiopathology | Male | Amides - therapeutic use | Heart Failure - blood | Renin - blood | Heart Failure - drug therapy | Stroke Volume | Glomerular Filtration Rate - drug effects | Renin - antagonists & inhibitors | Fumarates - pharmacology | Female | Renal Circulation - drug effects | Renin-Angiotensin System - drug effects | Aged | Blood Pressure - drug effects | Drug Therapy, Combination | Heart failure | Care and treatment | Cardiac patients | Angiotensin | Blood flow | Plasma | Review boards | Laboratories | Rodents | Mortality | Drug therapy | Drug dosages
Cardiovascular | MORTALITY | VAL-HEFT | BASE-LINE | METAANALYSIS | MYOCARDIAL-INFARCTION | CONVERTING-ENZYME-INHIBITION | KIDNEY-FUNCTION | RANDOMIZED-TRIAL | CARDIORENAL END-POINTS | PROGNOSTIC VALUE | CARDIAC & CARDIOVASCULAR SYSTEMS | Amides - pharmacology | Fumarates - therapeutic use | Humans | Middle Aged | Heart Failure - physiopathology | Male | Amides - therapeutic use | Heart Failure - blood | Renin - blood | Heart Failure - drug therapy | Stroke Volume | Glomerular Filtration Rate - drug effects | Renin - antagonists & inhibitors | Fumarates - pharmacology | Female | Renal Circulation - drug effects | Renin-Angiotensin System - drug effects | Aged | Blood Pressure - drug effects | Drug Therapy, Combination | Heart failure | Care and treatment | Cardiac patients | Angiotensin | Blood flow | Plasma | Review boards | Laboratories | Rodents | Mortality | Drug therapy | Drug dosages
Journal Article
Transplant International, ISSN 0934-0874, 11/2016, Volume 29, Issue 11, pp. 1176 - 1183
Anemia, iron deficiency anemia (IDA), and iron deficiency (ID) are highly prevalent in renal transplant recipients (RTR). Anemia is associated with poor...
C-REACTIVE PROTEIN | MANAGEMENT | RATIONALE | kidney transplantation | RISK | FAILURE | anemia | METABOLISM | INFLAMMATION | mortality | iron deficiency | POSTTRANSPLANTATION ANEMIA | CORONARY-HEART-DISEASE | KIDNEY | SURGERY | TRANSPLANTATION | Multivariate Analysis | Glomerular Filtration Rate | Prevalence | Prospective Studies | Renal Insufficiency - surgery | Follow-Up Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Transplant Recipients | Renal Insufficiency - mortality | Iron - deficiency | Adult | Female | Kidney Transplantation - mortality | Aged | Anemia, Iron-Deficiency - complications | Anemia, Iron-Deficiency - metabolism | Iron - blood | Kidneys | Iron deficiency anemia | Analysis | Mortality | Organ transplant recipients | Transplantation | Health aspects | Health risk assessment | Anemia
C-REACTIVE PROTEIN | MANAGEMENT | RATIONALE | kidney transplantation | RISK | FAILURE | anemia | METABOLISM | INFLAMMATION | mortality | iron deficiency | POSTTRANSPLANTATION ANEMIA | CORONARY-HEART-DISEASE | KIDNEY | SURGERY | TRANSPLANTATION | Multivariate Analysis | Glomerular Filtration Rate | Prevalence | Prospective Studies | Renal Insufficiency - surgery | Follow-Up Studies | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Transplant Recipients | Renal Insufficiency - mortality | Iron - deficiency | Adult | Female | Kidney Transplantation - mortality | Aged | Anemia, Iron-Deficiency - complications | Anemia, Iron-Deficiency - metabolism | Iron - blood | Kidneys | Iron deficiency anemia | Analysis | Mortality | Organ transplant recipients | Transplantation | Health aspects | Health risk assessment | Anemia
Journal Article
Scientific Reports, ISSN 2045-2322, 10/2017, Volume 7, Issue 1, pp. 14264 - 9
Haptoglobin (Hp) is an acute phase protein that has recently been linked to components of the metabolic syndrome (MetS). We aimed to evaluate Hp as marker of...
PERFORMANCE LIQUID-CHROMATOGRAPHY | MORTALITY | OBESITY | PROTEIN | MARKER | INSULIN-RESISTANCE | MISSING DATA | RISK | MULTIPLE IMPUTATION | INTERLEUKIN-6 | HEMOGLOBIN | MULTIDISCIPLINARY SCIENCES | VALIDATION | Rejection | Plasma | Grafts | Haptoglobin | Mortality | Metabolic syndrome | Health risk assessment | Metabolic disorders | Kidney transplantation | Nutrition and Disease | HNE Nutrition and Disease | Chair Nutrition and Disease | Voeding en Ziekte | VLAG | HNE Voeding en Ziekte
PERFORMANCE LIQUID-CHROMATOGRAPHY | MORTALITY | OBESITY | PROTEIN | MARKER | INSULIN-RESISTANCE | MISSING DATA | RISK | MULTIPLE IMPUTATION | INTERLEUKIN-6 | HEMOGLOBIN | MULTIDISCIPLINARY SCIENCES | VALIDATION | Rejection | Plasma | Grafts | Haptoglobin | Mortality | Metabolic syndrome | Health risk assessment | Metabolic disorders | Kidney transplantation | Nutrition and Disease | HNE Nutrition and Disease | Chair Nutrition and Disease | Voeding en Ziekte | VLAG | HNE Voeding en Ziekte
Journal Article
European Journal of Clinical Investigation, ISSN 0014-2972, 12/2016, Volume 46, Issue 12, pp. 994 - 1001
Background Hepcidin is considered the master regulator of iron homoeostasis. Novel hepcidin antagonists have recently been introduced as potential treatment...
hepcidin | renal transplantation | FERROPORTIN | graft failure | RECIPIENTS | GENERAL-POPULATION | MODULATES IRON-METABOLISM | CHRONIC DISEASE | SERUM HEPCIDIN | mortality | HEMODIALYSIS-PATIENTS | Determinants | ANEMIA | FERRITIN | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICINE, GENERAL & INTERNAL | Kidney Failure, Chronic - surgery | Prognosis | Prospective Studies | Enzyme-Linked Immunosorbent Assay | Acute Kidney Injury - blood | Humans | Middle Aged | Mortality | Proportional Hazards Models | Hepcidins - blood | Linear Models | Survival Rate | Kidney Transplantation | Cause of Death | C-Reactive Protein - metabolism | Ferritins - blood | Kidney Failure, Chronic - blood | Cardiovascular Diseases - blood | Cardiovascular Diseases - mortality | Adult | Kidneys | Analysis | Ferritin | Hemoglobin | Organ transplant recipients | Transplantation | Immunoassay | Transplants & implants | Antagonists | Iron | Grafting | Proteins | Confidence intervals | Regression models | Failure analysis | Enzyme-linked immunosorbent assay | Statistical analysis | Anemia | Therapeutic applications | Health risks | Regression analysis | Survival | Glomerular filtration rate | Rejection | Grafts | Cardiovascular diseases | Health risk assessment | Hepcidin | Kidney transplantation | Original
hepcidin | renal transplantation | FERROPORTIN | graft failure | RECIPIENTS | GENERAL-POPULATION | MODULATES IRON-METABOLISM | CHRONIC DISEASE | SERUM HEPCIDIN | mortality | HEMODIALYSIS-PATIENTS | Determinants | ANEMIA | FERRITIN | MEDICINE, RESEARCH & EXPERIMENTAL | MEDICINE, GENERAL & INTERNAL | Kidney Failure, Chronic - surgery | Prognosis | Prospective Studies | Enzyme-Linked Immunosorbent Assay | Acute Kidney Injury - blood | Humans | Middle Aged | Mortality | Proportional Hazards Models | Hepcidins - blood | Linear Models | Survival Rate | Kidney Transplantation | Cause of Death | C-Reactive Protein - metabolism | Ferritins - blood | Kidney Failure, Chronic - blood | Cardiovascular Diseases - blood | Cardiovascular Diseases - mortality | Adult | Kidneys | Analysis | Ferritin | Hemoglobin | Organ transplant recipients | Transplantation | Immunoassay | Transplants & implants | Antagonists | Iron | Grafting | Proteins | Confidence intervals | Regression models | Failure analysis | Enzyme-linked immunosorbent assay | Statistical analysis | Anemia | Therapeutic applications | Health risks | Regression analysis | Survival | Glomerular filtration rate | Rejection | Grafts | Cardiovascular diseases | Health risk assessment | Hepcidin | Kidney transplantation | Original
Journal Article
Nanomedicine, ISSN 1743-5889, 2013, Volume 8, Issue 7, pp. 1127 - 1135
The conventional clinical formulation of paclitaxel (PTX), Taxol®, consists of Cremophor® EL (CrEL) and ethanol. CrEL-formulated PTX is associated with acute...
paclitaxel | phosphatidylserine | microvesicle | human umbilical vein endothelial cell | Taxol | Abraxane | Cremophor | excipient | red blood cell | vehicle | Hemolysis - drug effects | Human Umbilical Vein Endothelial Cells - drug effects | Glycerol - adverse effects | Humans | Cells, Cultured | Phosphatidylserines - chemistry | Paclitaxel - adverse effects | Phosphatidylserines - adverse effects | Chemistry, Pharmaceutical | Erythrocytes - drug effects | Paclitaxel - chemistry | Flow Cytometry | Human Umbilical Vein Endothelial Cells - cytology | Erythrocytes - cytology | Glycerol - analogs & derivatives | Glycerol - chemistry
paclitaxel | phosphatidylserine | microvesicle | human umbilical vein endothelial cell | Taxol | Abraxane | Cremophor | excipient | red blood cell | vehicle | Hemolysis - drug effects | Human Umbilical Vein Endothelial Cells - drug effects | Glycerol - adverse effects | Humans | Cells, Cultured | Phosphatidylserines - chemistry | Paclitaxel - adverse effects | Phosphatidylserines - adverse effects | Chemistry, Pharmaceutical | Erythrocytes - drug effects | Paclitaxel - chemistry | Flow Cytometry | Human Umbilical Vein Endothelial Cells - cytology | Erythrocytes - cytology | Glycerol - analogs & derivatives | Glycerol - chemistry
Journal Article
The American Journal of Clinical Nutrition, ISSN 0002-9165, 12/2016, Volume 104, Issue 6, p. 1703
Background: Renal transplant recipients (RTRs) have commonly been urged to limit their potassium intake during renal insufficiency and may adhere to this...
Ammonia | Kidneys | Transplants & implants | Mortality | Potassium | Risk factors
Ammonia | Kidneys | Transplants & implants | Mortality | Potassium | Risk factors
Journal Article
Scientific Reports, ISSN 2045-2322, 2017, Volume 7
Haptoglobin (Hp) is an acute phase protein that has recently been linked to components of the metabolic syndrome (MetS). We aimed to evaluate Hp as marker of...
Nutrition and Disease | VLAG | HNE Nutrition and Disease | Chair Nutrition and Disease | Voeding en Ziekte | HNE Voeding en Ziekte
Nutrition and Disease | VLAG | HNE Nutrition and Disease | Chair Nutrition and Disease | Voeding en Ziekte | HNE Voeding en Ziekte
Journal Article
Bmc cardiovascular disorders, ISSN 1471-2261, 09/2012, Volume 12, Issue 1, pp. 76 - 76
Background: Atherosclerotic renal artery stenosis (ARAS) is common in cardiovascular diseases and associated with hypertension, renal dysfunction and/or heart...
REVASCULARIZATION | LOWER-EXTREMITY | MANAGEMENT | Late gadolinium enhancement | DIASTOLIC HEART-FAILURE | EUROPEAN-SOCIETY | UMCG Approved | VASCULAR-DISEASE | Atherosclerotic renal artery stenosis | ANGIOPLASTY | Magnetic resonance imaging | TASK-FORCE | Cardiorenal failure | EJECTION FRACTION | RENOVASCULAR DISEASE | CHRONIC HEART-FAILURE | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK | Predictive Value of Tests | Cardio-Renal Syndrome - epidemiology | Prevalence | Prognosis | Renal Artery - pathology | Ventricular Function, Left | Erythropoietin - therapeutic use | Humans | Middle Aged | Netherlands - epidemiology | Renal Artery Obstruction - physiopathology | Heart Failure - physiopathology | Male | Atherosclerosis - epidemiology | Cardio-Renal Syndrome - pathology | Renal Insufficiency, Chronic - drug therapy | Organometallic Compounds | Renal Insufficiency, Chronic - epidemiology | Aged, 80 and over | Female | Heart Failure - epidemiology | Cardio-Renal Syndrome - physiopathology | Severity of Illness Index | Atherosclerosis - pathology | Renal Artery Obstruction - drug therapy | Atherosclerosis - drug therapy | Glomerular Filtration Rate | Hematinics - therapeutic use | Risk Assessment | Atherosclerosis - physiopathology | Risk Factors | Magnetic Resonance Angiography | Myocardium - pathology | Heart Failure - pathology | Chi-Square Distribution | Renal Insufficiency, Chronic - physiopathology | Heart Failure - drug therapy | Renal Insufficiency, Chronic - pathology | Cardio-Renal Syndrome - drug therapy | Renal Artery Obstruction - epidemiology | Stroke Volume | Magnetic Resonance Imaging | Contrast Media | Analysis of Variance | Meglumine | Fibrosis | Aged | Renal Artery Obstruction - pathology | Heart failure | Hypertension | Medical research | Erythropoietin | Stenosis | Research | Renal artery obstruction | Chronic kidney failure | Medicine, Experimental | Diagnosis | Diabetes | Cardiovascular disease | Heart attacks | Kidney diseases | Mortality
REVASCULARIZATION | LOWER-EXTREMITY | MANAGEMENT | Late gadolinium enhancement | DIASTOLIC HEART-FAILURE | EUROPEAN-SOCIETY | UMCG Approved | VASCULAR-DISEASE | Atherosclerotic renal artery stenosis | ANGIOPLASTY | Magnetic resonance imaging | TASK-FORCE | Cardiorenal failure | EJECTION FRACTION | RENOVASCULAR DISEASE | CHRONIC HEART-FAILURE | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK | Predictive Value of Tests | Cardio-Renal Syndrome - epidemiology | Prevalence | Prognosis | Renal Artery - pathology | Ventricular Function, Left | Erythropoietin - therapeutic use | Humans | Middle Aged | Netherlands - epidemiology | Renal Artery Obstruction - physiopathology | Heart Failure - physiopathology | Male | Atherosclerosis - epidemiology | Cardio-Renal Syndrome - pathology | Renal Insufficiency, Chronic - drug therapy | Organometallic Compounds | Renal Insufficiency, Chronic - epidemiology | Aged, 80 and over | Female | Heart Failure - epidemiology | Cardio-Renal Syndrome - physiopathology | Severity of Illness Index | Atherosclerosis - pathology | Renal Artery Obstruction - drug therapy | Atherosclerosis - drug therapy | Glomerular Filtration Rate | Hematinics - therapeutic use | Risk Assessment | Atherosclerosis - physiopathology | Risk Factors | Magnetic Resonance Angiography | Myocardium - pathology | Heart Failure - pathology | Chi-Square Distribution | Renal Insufficiency, Chronic - physiopathology | Heart Failure - drug therapy | Renal Insufficiency, Chronic - pathology | Cardio-Renal Syndrome - drug therapy | Renal Artery Obstruction - epidemiology | Stroke Volume | Magnetic Resonance Imaging | Contrast Media | Analysis of Variance | Meglumine | Fibrosis | Aged | Renal Artery Obstruction - pathology | Heart failure | Hypertension | Medical research | Erythropoietin | Stenosis | Research | Renal artery obstruction | Chronic kidney failure | Medicine, Experimental | Diagnosis | Diabetes | Cardiovascular disease | Heart attacks | Kidney diseases | Mortality
Journal Article
Clinical Chemistry and Laboratory Medicine, ISSN 1434-6621, 09/2007, Volume 45, Issue 9, pp. 1109 - 1120
Prevention of cardiovascular disease (CVD) remains a major health issue in the Western world. The diagnostic and therapeutic approach is currently based on...
Phenotype | Inflammation | Monocyte | Cardiovascular risk factor | Microarrays | phenotype | C-REACTIVE PROTEIN | RHEUMATOID-ARTHRITIS | SIGNATURES | GENE-EXPRESSION PROFILES | cardiovascular risk factor | BLOOD MONONUCLEAR-CELLS | MICROARRAY ANALYSIS | microarrays | BIOMARKERS | WHOLE-BLOOD | inflammation | IN-VIVO | monocyte | MEDICAL LABORATORY TECHNOLOGY | ISCHEMIC-STROKE | Atherosclerosis - pathology | Reproducibility of Results | Atherosclerosis - genetics | Genomics | Humans | Risk Factors | Monocytes - metabolism | Reference Values | Gene Expression Profiling | Cardiovascular Diseases - pathology | Cardiovascular Diseases - genetics | Atherosclerosis - diagnosis | Biomarkers | Protein Array Analysis | Transcription, Genetic | Leukocytes - metabolism | Cardiovascular Diseases - diagnosis
Phenotype | Inflammation | Monocyte | Cardiovascular risk factor | Microarrays | phenotype | C-REACTIVE PROTEIN | RHEUMATOID-ARTHRITIS | SIGNATURES | GENE-EXPRESSION PROFILES | cardiovascular risk factor | BLOOD MONONUCLEAR-CELLS | MICROARRAY ANALYSIS | microarrays | BIOMARKERS | WHOLE-BLOOD | inflammation | IN-VIVO | monocyte | MEDICAL LABORATORY TECHNOLOGY | ISCHEMIC-STROKE | Atherosclerosis - pathology | Reproducibility of Results | Atherosclerosis - genetics | Genomics | Humans | Risk Factors | Monocytes - metabolism | Reference Values | Gene Expression Profiling | Cardiovascular Diseases - pathology | Cardiovascular Diseases - genetics | Atherosclerosis - diagnosis | Biomarkers | Protein Array Analysis | Transcription, Genetic | Leukocytes - metabolism | Cardiovascular Diseases - diagnosis
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2009, Volume 53, Issue 15, pp. 1340 - 1340
In our view these connectors are, in addition to the well-known hemodynamic interactions between heart and kidney, responsible for the strongly progressive...
CARDIAC & CARDIOVASCULAR SYSTEMS | Heart Failure - complications | Renal Insufficiency - complications | Heart Failure - classification | Humans | Syndrome | Renal Insufficiency - classification | Heart failure | Classification | Chronic illnesses
CARDIAC & CARDIOVASCULAR SYSTEMS | Heart Failure - complications | Renal Insufficiency - complications | Heart Failure - classification | Humans | Syndrome | Renal Insufficiency - classification | Heart failure | Classification | Chronic illnesses
Journal Article
The American Journal of Medicine, ISSN 0002-9343, 2000, Volume 108, Issue 5, pp. 421 - 423
MEDICINE, GENERAL & INTERNAL | TISSUE FACTOR | Recombinant Proteins - therapeutic use | Recurrence | Reoperation | Humans | Middle Aged | Peptic Ulcer Hemorrhage - surgery | Male | Treatment Outcome | Factor VIIa - therapeutic use | Hematemesis - etiology | Peptic Ulcer Hemorrhage - drug therapy | Peptic Ulcer Hemorrhage - complications | Treatment Failure | Laparotomy | Melena - etiology | Care and treatment | Blood coagulation factor VIII | Gastrointestinal bleeding | Health aspects | Hemorrhage
Journal Article
Nanomedicine, ISSN 1743-5889, 07/2013, Volume 8, Issue 7, pp. 1127 - 1135
Aim: The conventional clinical formulation of paclitaxel (PTX), Taxol super( registered ), consists of Cremophor super( registered ) EL (CrEL) and ethanol....
Journal Article
Nature Clinical Practice Nephrology, ISSN 1745-8323, 01/2008, Volume 4, Issue 1, pp. 47 - 57
Anemia is common in patients who have both heart failure and kidney disease, and there is an association between anemia progression of both diseases. The main...
Heart failure | Chronic kidney disease | Inflammation | Erythropoietin resistance | Anemia | heart failure | HEMATOCRIT VALUES | chronic kidney disease | erythropoietin resistance | EPOETIN-ALPHA | anemia | II RECEPTOR BLOCKERS | ACE-INHIBITORS | TUMOR-NECROSIS-FACTOR | inflammation | INCIDENT HEMODIALYSIS-PATIENTS | GENE-EXPRESSION | UROLOGY & NEPHROLOGY | CARDIORENAL SYNDROME | EPO RECEPTOR | CHRONIC-RENAL-FAILURE | Anemia - physiopathology | Heart Failure - complications | Anemia - drug therapy | Erythropoietin - therapeutic use | Humans | Renal Insufficiency - complications | Anemia - etiology | Drug Resistance
Heart failure | Chronic kidney disease | Inflammation | Erythropoietin resistance | Anemia | heart failure | HEMATOCRIT VALUES | chronic kidney disease | erythropoietin resistance | EPOETIN-ALPHA | anemia | II RECEPTOR BLOCKERS | ACE-INHIBITORS | TUMOR-NECROSIS-FACTOR | inflammation | INCIDENT HEMODIALYSIS-PATIENTS | GENE-EXPRESSION | UROLOGY & NEPHROLOGY | CARDIORENAL SYNDROME | EPO RECEPTOR | CHRONIC-RENAL-FAILURE | Anemia - physiopathology | Heart Failure - complications | Anemia - drug therapy | Erythropoietin - therapeutic use | Humans | Renal Insufficiency - complications | Anemia - etiology | Drug Resistance
Journal Article
Physics Letters B, ISSN 0370-2693, 05/2002, Volume 534, Issue 1-4, pp. 28 - 38
A Higgs particle produced in association with a Z boson and decaying into two photons is searched for in the data collected by the L3 experiment at LEP. All...
international | STANDARD MODEL | L3 EXPERIMENT | FINAL-STATES | PHYSICS, MULTIDISCIPLINARY | FERMIOPHOBIC HIGGS | DETECTOR | E(+)E(-) COLLISIONS | W-PAIR PRODUCTION | MONTE-CARLO PROGRAM | PHOTOPRODUCTION | BHABHA SCATTERING | Physics - High Energy Physics - Experiment | Physics | High Energy Physics - Experiment
international | STANDARD MODEL | L3 EXPERIMENT | FINAL-STATES | PHYSICS, MULTIDISCIPLINARY | FERMIOPHOBIC HIGGS | DETECTOR | E(+)E(-) COLLISIONS | W-PAIR PRODUCTION | MONTE-CARLO PROGRAM | PHOTOPRODUCTION | BHABHA SCATTERING | Physics - High Energy Physics - Experiment | Physics | High Energy Physics - Experiment
Journal Article
Leukemia, ISSN 0887-6924, 2012, Volume 26, Issue 9, pp. 2103 - 2113
Gene expression profiling (GEP) has stratified diffuse large B-cell lymphoma (DLBCL) into molecular subgroups that correspond to different stages of lymphocyte...
ABC-DLBCL | diffuse large B-cell lymphoma | BCL6 | GCB-DLBCL | CD10 | FOXP1 | PROGNOSTIC IMPACT | IMMUNOCHEMOTHERAPY | PROTEIN | R-CHOP | HGAL | CHEMOTHERAPY | ONCOLOGY | PREDICTS SURVIVAL | DIFFERENTIATION | HEMATOLOGY | TRANSCRIPTION FACTOR | Cyclophosphamide - administration & dosage | Prednisone - administration & dosage |
ABC-DLBCL | diffuse large B-cell lymphoma | BCL6 | GCB-DLBCL | CD10 | FOXP1 | PROGNOSTIC IMPACT | IMMUNOCHEMOTHERAPY | PROTEIN | R-CHOP | HGAL | CHEMOTHERAPY | ONCOLOGY | PREDICTS SURVIVAL | DIFFERENTIATION | HEMATOLOGY | TRANSCRIPTION FACTOR | Cyclophosphamide - administration & dosage | Prednisone - administration & dosage |